Terms: = Breast cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Prognosis
52 results:
1. Alterations in the mammary gland and tumor microenvironment of formerly obese mice.
Kuziel G; Moore BN; Haugstad GP; Xiong Y; Williams AE; Arendt LM
BMC Cancer; 2023 Dec; 23(1):1183. PubMed ID: 38041006
[TBL] [Abstract] [Full Text] [Related]
2. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
3. Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.
Shamis SA; Savioli F; Ammar A; Al-Badran SS; Hatthakarnkul P; Leslie H; Mallon EE; Jamieson NB; McMillan DC; Edwards J
Histol Histopathol; 2024 Feb; 39(2):177-200. PubMed ID: 37681672
[TBL] [Abstract] [Full Text] [Related]
4. NK cells in peripheral blood carry trogocytosed tumor antigens from solid cancer cells.
Campos-Mora M; Jacot W; Garcin G; Depondt ML; Constantinides M; Alexia C; Villalba M
Front Immunol; 2023; 14():1199594. PubMed ID: 37593736
[TBL] [Abstract] [Full Text] [Related]
5. ptprc promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification.
Li P; Wang W; Wang S; Cao G; Pan T; Huang Y; Wan H; Zhang W; Huang Y; Jin H; Wang Z
Front Immunol; 2023; 14():1145481. PubMed ID: 37388747
[TBL] [Abstract] [Full Text] [Related]
6. Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer.
Ding S; Qiao N; Zhu Q; Tong Y; Wang S; Chen X; Tian Q; Xiao Y; Shen K
Cancer Commun (Lond); 2023 Jun; 43(6):661-684. PubMed ID: 37158690
[TBL] [Abstract] [Full Text] [Related]
7. CD47 and CD68 expression in breast cancer is associated with tumor-infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis.
Chen Y; Klingen TA; Aas H; Wik E; Akslen LA
J Pathol Clin Res; 2023 May; 9(3):151-164. PubMed ID: 36598153
[TBL] [Abstract] [Full Text] [Related]
8. CD20
Wu Z; Zhou J; Xiao Y; Ming J; Zhou J; Dong F; Zhou X; Xu Z; Zhao X; Lei P; Huang T
Front Immunol; 2022; 13():865596. PubMed ID: 35634306
[TBL] [Abstract] [Full Text] [Related]
9. Rapid and efficient capturing of circulating tumor cells from breast cancer Patient's whole blood via the antibody functionalized microfluidic (AFM) chip.
Abdulla A; Zhang Z; Ahmad KZ; Warden AR; Li H; Ding X
Biosens Bioelectron; 2022 Apr; 201():113965. PubMed ID: 35016111
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of ER, PR and HER2 markers by flow cytometry for breast cancer diagnosis and prognosis.
Wopereis S; Walter LO; Vieira DSC; Ribeiro AAB; Fernandes BL; Wilkens RS; Santos-Silva MC
Clin Chim Acta; 2021 Dec; 523():504-512. PubMed ID: 34762935
[TBL] [Abstract] [Full Text] [Related]
11. Circulating tumour cells at baseline and late phase of treatment provide prognostic value in breast cancer.
Pang S; Li H; Xu S; Feng L; Ma X; Chu Y; Zou B; Wang S; Zhou G
Sci Rep; 2021 Jun; 11(1):13441. PubMed ID: 34188122
[TBL] [Abstract] [Full Text] [Related]
12. Tumor-associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer.
Chen Y; Klingen TA; Aas H; Wik E; Akslen LA
J Pathol Clin Res; 2021 Sep; 7(5):517-527. PubMed ID: 34076969
[TBL] [Abstract] [Full Text] [Related]
13. Transcriptomic Profiles of CD47 in breast Tumors Predict Outcome and Are Associated with Immune Activation.
Noblejas-López MDM; Baliu-Piqué M; Nieto-Jiménez C; Cimas FJ; Morafraile EC; Pandiella A; Corbi ÁL; Győrffy B; Ocaña A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917174
[TBL] [Abstract] [Full Text] [Related]
14. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy.
Hubert P; Roncarati P; Demoulin S; Pilard C; Ancion M; Reynders C; Lerho T; Bruyere D; Lebeau A; Radermecker C; Meunier M; Nokin MJ; Hendrick E; Peulen O; Delvenne P; Herfs M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33712445
[TBL] [Abstract] [Full Text] [Related]
15. Protein-based immune profiles of basal-like vs. luminal breast cancers.
Walens A; Olsson LT; Gao X; Hamilton AM; Kirk EL; Cohen SM; Midkiff BR; Xia Y; Sherman ME; Nikolaishvili-Feinberg N; Serody JS; Hoadley KA; Troester MA; Calhoun BC
Lab Invest; 2021 Jun; 101(6):785-793. PubMed ID: 33623115
[TBL] [Abstract] [Full Text] [Related]
16. Increased Stromal Infiltrating Lymphocytes Are Associated with the Risk of Disease Progression in Mesenchymal Circulating Tumor Cell-Positive Primary breast cancer Patients.
Smolkova B; Cierna Z; Kalavska K; Miklikova S; Plava J; Minarik G; Sedlackova T; Cholujova D; Gronesova P; Cihova M; Majerova K; Karaba M; Benca J; Pindak D; Mardiak J; Mego M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322711
[TBL] [Abstract] [Full Text] [Related]
17. Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer.
Kim JY; Jung HH; Sohn I; Woo SY; Cho H; Cho EY; Lee JE; Kim SW; Nam SJ; Park YH; Ahn JS; Im YH
Breast Cancer Res Treat; 2020 Nov; 184(2):325-334. PubMed ID: 32812178
[TBL] [Abstract] [Full Text] [Related]
18. Database Mining of Genes of Prognostic Value for the Prostate Adenocarcinoma Microenvironment Using the cancer Gene Atlas.
Zhao X; Hu D; Li J; Zhao G; Tang W; Cheng H
Biomed Res Int; 2020; 2020():5019793. PubMed ID: 32509861
[TBL] [Abstract] [Full Text] [Related]
19. Metabolic classification of circulating tumor cells as a biomarker for metastasis and prognosis in breast cancer.
Chen J; Ye C; Dong J; Cao S; Hu Y; Situ B; Xi X; Qin S; Xu J; Cai Z; Zheng L; Wang Q
J Transl Med; 2020 Feb; 18(1):59. PubMed ID: 32028979
[TBL] [Abstract] [Full Text] [Related]
20. Baseline circulating stem-like cells predict survival in patients with metastatic breast cancer.
Lee CH; Hsieh JC; Wu TM; Yeh TS; Wang HM; Lin YC; Chen JS; Lee CL; Huang WK; Hung TM; Yen TT; Chan SC; Chou WC; Kuan FC; Hu CC; Chang PH
BMC Cancer; 2019 Dec; 19(1):1167. PubMed ID: 31791269
[TBL] [Abstract] [Full Text] [Related]
[Next]